日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Variation in presepsin and thrombomodulin levels for predicting COVID-19 mortality

前降钙素原和血栓调节蛋白水平的变化可用于预测新冠肺炎死亡率

Yamazaki, Azusa; Nukui, Yoko; Kameda, Takahiro; Saito, Ryoichi; Koda, Yuki; Ichimura, Naoya; Tohda, Shuji; Ohkawa, Ryunosuke

Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model

阿普斯特对系统性硬化症真皮成纤维细胞和博来霉素诱导的小鼠模型的抗纤维化作用

Tomoaki Higuchi, Kae Takagi, Akiko Tochimoto, Yuki Ichimura, Hikaru Hirose, Tatsuo Sawada, Noriyuki Shibata, Masayoshi Harigai, Yasushi Kawaguchi

Combination Treatment of Topical Imiquimod Plus Anti-PD-1 Antibody Exerts Significantly Potent Antitumor Effect

局部咪喹莫特与抗 PD-1 抗体联合治疗具有显著的抗肿瘤作用

Kazumasa Oya, Yoshiyuki Nakamura, Zhu Zhenjie, Ryota Tanaka, Naoko Okiyama, Yuki Ichimura, Yosuke Ishitsuka, Akimasa Saito, Noriko Kubota, Rei Watanabe, Hideaki Tahara, Manabu Fujimoto, Yasuhiro Fujisawa

Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment

2-碳环磷脂酸 (2ccPA) 在系统性硬化症中的抗纤维化作用:对新疗法的贡献

Tomoaki Higuchi, Kae Takagi, Akiko Tochimoto, Yuki Ichimura, Takanari Norose, Yasuhiro Katsumata, Ikuko Masuda, Hisashi Yamanaka, Toshiro Morohoshi, Yasushi Kawaguchi

Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy

成人特发性炎症性肌病患者的抗 NXP2 自身抗体:可能与恶性肿瘤有关

Yuki Ichimura, Takashi Matsushita, Yasuhito Hamaguchi, Kenzo Kaji, Minoru Hasegawa, Yoshinori Tanino, Yayoi Inokoshi, Kazuhiro Kawai, Takuro Kanekura, Maria Habuchi, Atsuyuki Igarashi, Ryosuke Sogame, Takashi Hashimoto, Tomohiro Koga, Ayako Nishino, Naoko Ishiguro, Naoki Sugimoto, Rui Aoki, Noriko A